Ginkgo Bioworks (DNA) Earnings Date, Estimates & Call Transcripts $8.12 +0.41 (+5.32%) (As of 10/3/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 13EstimatedActual EPS (Aug. 8) -$0.08 Consensus EPS (Aug. 8) -$0.08 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DNA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Ginkgo Bioworks Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.08)($0.08)($0.08) Q2 20241($0.08)($0.08)($0.08) Q3 20241($0.08)($0.08)($0.08) Q4 20241($0.08)($0.08)($0.08) FY 20244($0.32)($0.32)($0.32) Q1 20251($0.08)($0.08)($0.08) Q2 20251($0.07)($0.07)($0.07) Q3 20251($0.08)($0.08)($0.08) Q4 20251($0.07)($0.07)($0.07) FY 20254($0.30)($0.30) ($0.30)DNA Earnings Date and InformationGinkgo Bioworks last announced its earnings results on August 8th, 2024. The reported ($0.08) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.08). The firm had revenue of $56.21 million for the quarter, compared to analyst estimates of $41.46 million. Ginkgo Bioworks has generated ($0.44) earnings per share over the last year (($0.44) diluted earnings per share). Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($12.60) to ($6.80) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off prior year's report dates.Read More Ginkgo Bioworks Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/13/2024(Estimated)------- 8/8/2024Q2 2024($0.08)($0.08)-($2.00)$41.46 million$56.21 million5/9/2024Q1 2024($0.0020)($0.0020)-($0.08)$45.50 million$37.94 million 2/29/2024Q4 2023($0.0023)($0.0025)($0.0003)($0.07)$40.37 million$34.76 million 11/8/2023Q3 2023($0.0023)($0.0023)-($0.02)$46.47 million$55.43 million 8/9/2023Q2 2023($0.0023)($0.0023)-($0.09)$70.41 million$80.57 million 5/10/2023Q1 2023($0.0023)($0.0020)+$0.0003($0.05)$62.04 million$80.70 million The massive trade idea that’s being censored (Ad)There is a red-hot sector right now that it seems like Google doesn’t want us to talk about… Because when we talk about it in email, sometimes those messages have trouble making it through to you. And it’s not just email! Videos from Youtube are also being removed. We don’t know exactly why it’s happening… Or if it’s being done manually or by an algorithm…. But we do know that you probably are going to want to see what they’re censoring.Decide for yourself when you get the full details here.3/1/2023Q4 2022($0.0075)($0.0010)+$0.0065$0.02$84.41 million$98.29 million 11/14/2022Q3 2022($0.0063)($0.01)($0.0038)($0.39)$54.28 million$66.40 million 8/15/2022Q2 2022($0.0013)($0.0103)($0.0090)($0.41)$69.95 million$144.62 million 5/16/2022Q1 2022($0.0010)($0.0013)($0.0003)$0.27$100.15 million$168.41 million 3/28/2022Q4 2021($0.0013)($0.0003)+$0.0010$1.08$107.00 million$148.49 million 11/15/2021Q3 2021($0.0010)($0.0018)($0.0008)($0.06)$46.00 million$77.61 million Ginkgo Bioworks Earnings - Frequently Asked Questions When is Ginkgo Bioworks's earnings date? Ginkgo Bioworks has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates. Learn more on DNA's earnings history. What guidance has Ginkgo Bioworks issued on next quarter's earnings? Ginkgo Bioworks updated its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $170.0 million-$190.0 million, compared to the consensus revenue estimate of $179.5 million. Did Ginkgo Bioworks beat their earnings estimates last quarter? In the previous quarter, Ginkgo Bioworks (NYSE:DNA) reported ($0.08) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.08). Learn more on analysts' earnings estimate vs. DNA's actual earnings. How much revenue does Ginkgo Bioworks generate each year? Ginkgo Bioworks (NYSE:DNA) has a recorded annual revenue of $184.34 million. How much profit does Ginkgo Bioworks generate each year? Ginkgo Bioworks (NYSE:DNA) has a recorded net income of -$892.87 million. DNA has generated -$0.44 earnings per share over the last four quarters. What is Ginkgo Bioworks's EPS forecast for next year? Ginkgo Bioworks's earnings are expected to grow from ($12.60) per share to ($6.80) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Kiniksa Pharmaceuticals Earnings Arvinas Earnings Rocket Pharmaceuticals Earnings Syndax Pharmaceuticals Earnings Centessa Pharmaceuticals Earnings Immunocore Earnings Ardelyx Earnings Kura Oncology Earnings NewAmsterdam Pharma Earnings Arcus Biosciences Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NYSE:DNA) was last updated on 10/3/2024 by MarketBeat.com Staff From Our PartnersThe world’s smartest man is in their crosshairsElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredMassive NVIDIA Sell-Off: Are We Headed for a Market Collapse?You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this ye...Behind the Markets | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Ginkgo Bioworks Holdings, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Ginkgo Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
